Literature DB >> 6798973

Induction, immunochemical identity and immunofluorescence localization of an 80 000-molecular-weight peroxisome-proliferation-associated polypeptide (polypeptide PPA-80) and peroxisomal enoyl-CoA hydratase of mouse liver and renal cortex.

N D Lalwani, M K Reddy, M Mangkornkanok-Mark, J K Reddy.   

Abstract

The hypolipidaemic drugs methyl clofenapate, BR-931, Wy-14643 and procetofen induced a marked proliferation of peroxisomes in the parenchymal cells of liver and the proximal-convoluted-tubular epithelium of mouse kidney. The proliferation of peroxisomes was associated with 6-12-fold increase in the peroxisomal palmitoyl-CoA oxidizing capacity of the mouse liver. Enhanced activity of the peroxisomal palmitoyl-CoA oxidation system was also found in the renal-cortical homogenates of hypolipidaemic-drug-treated mice. The activity of enoyl-CoA hydratase in the mouse liver increased 30-50-fold and in the kidney cortex 3-5-fold with hypolipidaemic-drug-induced peroxisome proliferation in these tissues, and over 95% of this induced activity was found to be heat-labile peroxisomal enzyme in both organs. Sodium dodecyl sulphate/polyacrylamide-gel-electrophoretic analysis of large-particle and microsomal fractions obtained from the liver and kidney cortex of mice treated with hypolipidaemic peroxisome proliferators demonstrated a substantial increase in the quantity of an 80000-mol.wt. peroxisome-proliferation-associated polypeptide (polypeptide PPA-80). The heat-labile peroxisomal enoyl-CoA hydratase was purified from the livers of mice treated with the hypolipidaemic drug methyl clofenapate; the antibodies raised against this electrophoretically homogeneous protein yielded a single immunoprecipitin band with purified mouse liver enoyl-CoA hydratase and with liver and kidney cortical extracts of normal and hypolipidaemic-drug-treated mice. These anti-(mouse liver enoyl-CoA hydratase) antibodies also cross-reacted with purified rat liver enoyl-CoA hydratase and with the polypeptide PPA-80 obtained from rat and mouse liver. Immunofluorescence studies with anti-(polypeptide PPA-80) and anti-(peroxisomal enoyl-CoA hydratase) provided visual evidence for the localization and induction of polypeptide PPA-80 and peroxisomal enoyl-CoA hydratase in the liver and kidney respectively of normal and hypolipidaemic-drug-treated mice. In the kidney, the distribution of these two proteins is identical and limited exclusively to the cytoplasm of proximal-convoluted-tubular epithelium. The immunofluorescence studies clearly complement the biochemical and ultrastructural observations of peroxisome induction in the liver and kidney cortex of mice fed on hypolipidaemic drugs. In addition, preliminary ultrastructural studies with the protein-A-gold-complex technique demonstrate that the heat-labile hepatic enoyl-CoA hydratase is localized in the peroxisome matrix.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6798973      PMCID: PMC1163224          DOI: 10.1042/bj1980177

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Bovine liver crotonase (enoyl coenzyme A hydratase). EC 4.2.1.17 L-3-hydroxyacyl-CoA hydrolyase.

Authors:  H M Steinman; R L Hill
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Oxidation of isotopic palmitic acid in animal tissues.

Authors:  S WEINHOUSE; R H MILLINGTON; M E VOLK
Journal:  J Biol Chem       Date:  1950-07       Impact factor: 5.157

Review 3.  Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs.

Authors:  J K Reddy
Journal:  J Histochem Cytochem       Date:  1973-11       Impact factor: 2.479

4.  Beta oxidation in glyoxysomes from castor bean endosperm.

Authors:  T G Cooper; H Beevers
Journal:  J Biol Chem       Date:  1969-07-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat.

Authors:  R Hess; W Stäubli; W Riess
Journal:  Nature       Date:  1965-11-27       Impact factor: 49.962

7.  Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.

Authors:  J K Reddy
Journal:  Am J Pathol       Date:  1974-04       Impact factor: 4.307

8.  Microbody (peroxisome) proliferation in mouse kidney induced by methyl clofenapate.

Authors:  J K Reddy; T P Krishnakantha; M S Rao
Journal:  Virchows Arch B Cell Pathol       Date:  1975

9.  Increase of hepatic mitochondria on administration of ethyl alpha-p-chlorophenoxyisobutyrate to the rat.

Authors:  C K Kurup; H N Aithal; T Ramasarma
Journal:  Biochem J       Date:  1970-03       Impact factor: 3.857

10.  Distribution of peroxisomes (microbodies) in the nephron of the rat: a cytochemical study.

Authors:  M E Beard; A B Novikoff
Journal:  J Cell Biol       Date:  1969-08       Impact factor: 10.539

View more
  14 in total

1.  Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids.

Authors:  Sander M Houten; Simone Denis; Carmen A Argmann; Yuzhi Jia; Sacha Ferdinandusse; Janardan K Reddy; Ronald J A Wanders
Journal:  J Lipid Res       Date:  2012-04-25       Impact factor: 5.922

2.  Isolation of peroxisomal enoyl-CoA hydratase in rainbow trout and immunochemical identification with the bifunctional enzyme.

Authors:  L A Baldwin; E J Calabrese; P T Kostecki; J H Yang
Journal:  Fish Physiol Biochem       Date:  1990-07       Impact factor: 2.794

3.  Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal beta-oxidation.

Authors:  T Borges; L W Robertson; R E Peterson; H P Glauert
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

4.  The biogenesis protein PEX14 is an optimal marker for the identification and localization of peroxisomes in different cell types, tissues, and species in morphological studies.

Authors:  Phillip Grant; Barbara Ahlemeyer; Srikanth Karnati; Timm Berg; Ingra Stelzig; Anca Nenicu; Klaus Kuchelmeister; Denis I Crane; Eveline Baumgart-Vogt
Journal:  Histochem Cell Biol       Date:  2013-10       Impact factor: 4.304

5.  Induction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye. A model system for the evaluation of xenobiotic-induced effects.

Authors:  M S Rao; S Thorgeirsson; M K Reddy; N D Lalwani; R E Evarts; M I Usman; B Singh; J K Reddy
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

6.  Induction of hepatic peroxisome proliferation in nonrodent species, including primates.

Authors:  J K Reddy; N D Lalwani; S A Qureshi; M K Reddy; C M Moehle
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

7.  Immunocytochemical demonstration of serine: pyruvate amino-transferase in peroxisomes and mitochondria of rat kidney.

Authors:  S Yokota; T Oda
Journal:  Histochemistry       Date:  1985

8.  Prevention of peroxisomal proliferation by carnitine palmitoyltransferase inhibitors in cultured rat hepatocytes and in vivo.

Authors:  R Hertz; J Bar-Tana
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

9.  Effects of high fat diets on the activity of palmitoyl-CoA hydrolase in rat liver.

Authors:  R K Berge; M S Thomassen
Journal:  Lipids       Date:  1985-01       Impact factor: 1.880

10.  Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.

Authors:  J K Reddy; M K Reddy; M I Usman; N D Lalwani; M S Rao
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.